Takeda Pharmaceutical Co: Under Agreement Ascentage Pharma to Receive Option Payment of $100 Mln Upon Signing of Exclusive Option to License Agreement
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.